Probi and BiO-LiFE start probiotic partnership
PROBI AB, a leading probiotic research and development company from Sweden, and BiO-LiFE, a healthcare company in the fast growing Asian vitamin and dietary supplements category, signed a partnership agreement for the launch of a probiotic product, in Malaysia during the second half of 2013 and with the intention to extend into other countries in South East Asia.
PROBI and BiO-LiFE have signed a long term agreement to partner for the branding and launch of PROBI’s Lactobacillus plantarum 299v (Probi Digestis®), a clinically documented probiotic product within the gastrointestinal field. BiO-LiFE will provide co-branding, product launch services, sales, marketing and technical services in the local market. BiO-LiFE is a growing healthcare subsidiary within DKSH, the leading Market Expansion Service provider with a focus on Asia, giving the opportunity to expand in the region.
The product will be marketed in a cobranded solution with BiO-LiFE and PROBI LP299V® and is positioned against Irritable Bowel Syndrome (IBS) symptom’s like abdominal pain, bloating, constipation and flatulence. PROBI LP299V® will be available at all leading pharmacies across Malaysia.
“BiO-LiFE is our partner of choice to launch and brand our probiotic product PROBI LP299V® in Malaysia, thanks to brand longevity in a key Asian market and their deep industry expertise. The BiO-LiFE brand has a very successful track record of promoting clinically proven Probiotic supplements. We look forward to growing our brand with the support of BiO-LiFE in Malaysia and other countries in the region,” says Gun-Britt Fransson, Interim CEO, Probi.
“We are very pleased to partner with PROBI AB, a leading company in probiotic research, for the launch and branding of PROBI LP299V® and bringing a clinically studied and unique product for the treatment of IBS related symptoms to the Malaysian market. We look forward to establishing the PROBI LP299V® brand in Malaysia,” comments John Goebel, General Manager, BiO-LiFE.
The information is such that Probi AB must disclose in accordance with the Swedish Securities Market Act and/or the Financial Instruments Trading Act.
FOR FURTHER INFORMATION, CONTACT:
Gun-Britt Fransson, Interim CEO, Probi, phone +46 46 286 89 74 or mobile +46 705 95 73 27, e-mail: gun-britt.fransson@probi.se
Niklas Bjärum, Vice President Marketing & Sales, Probi, phone +46 46 286 89 67 or mobile +46 705 38 88 64, e-mail: niklas.bjarum@probi.se
John Goebel, General Manager Asia, BiO-LiFE Marketing Sdn. Bhd. phone: +60 (0)3 7843 6981, e-mail:health@biolife.com.my
ABOUT PROBI
Probi is a leading player in probiotic research and development of effective and well-documented probiotics. The research areas are: the gastrointestinal tract, immune system, metabolic syndrome and stress and recovery. Probi’s customers are leading companies in the Functional Food and Consumer Healthcare segments. Total income for 2012 was MSEK 100.4. Probi’s share is listed on Nasdaq OMX Stockholm, Small Cap. Probi has approximately 5,000 shareholders. Read more on www.probi.se.
ABOUT BiO-LiFE
BiO-LiFE Marketing is a growing healthcare subsidiary within DKSH, the leading Market Expansion Services provider with a focus on Asia. The first BiO-LiFE branded products were launched in Malaysia in 1990. Since then, the brand has developed a wide range of quality and efficacious products, built on partnering with industry leaders for natural healthcare. Since our humble beginnings in 1990, BiO-LiFE has developed into one of the leading brands in Malaysia for natural health and dietary supplements, and is now also sold in many markets across South East Asia.
Tags: